Author/Creator: Funao, Nobuo - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Funao, Nobuo

1. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Issue 2 (13th August 2019)

Authors:: Xiao, Yinglian; Zhang, Shutian; Dai, Ning; Fei, Guijun; Goh, Khean-Lee; Chun, Hoon Jai; Sheu, Bor-Shyang; Chong, Chui Fung; Funao, Nobuo; Zhou, Wen; Chen, Minhu
Journal:: Gut
Issue:: Volume 69:Issue 2(2020)
Page Start:: 224
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Reply to the letter by Dr Graham concerning ethical and interpretation issues with vonoprazan-containing H. pylori eradication therapy. Issue 2 (3rd May 2016)

Authors:: Murakami, Kazunari; Sakurai, Yuuichi; Shiino, Madoka; Funao, Nobuo; Nishimura, Akira; Asaka, Masahiro
Journal:: Gut
Issue:: Volume 66:Issue 2(2017)
Page Start:: 386
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study. Issue 6 (1st December 2017)

Authors:: Kawai, Takashi; Oda, Kazunori; Funao, Nobuo; Nishimura, Akira; Matsumoto, Yasushi; Mizokami, Yuji; Ashida, Kiyoshi; Sugano, Kentaro
Journal:: Gut
Issue:: Volume 67:Issue 6(2018)
Page Start:: 1033
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study. Issue 6 (7th October 2017)

Authors:: Mizokami, Yuji; Oda, Kazunori; Funao, Nobuo; Nishimura, Akira; Soen, Satoshi; Kawai, Takashi; Ashida, Kiyoshi; Sugano, Kentaro
Journal:: Gut
Issue:: Volume 67:Issue 6(2018)
Page Start:: 1042
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Issue 9 (2nd March 2016)

Authors:: Murakami, Kazunari; Sakurai, Yuuichi; Shiino, Madoka; Funao, Nobuo; Nishimura, Akira; Asaka, Masahiro
Journal:: Gut
Issue:: Volume 65:Issue 9(2016)
Page Start:: 1439
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗